We serve Chemical Name:(1R)-1-(4-Bromophenyl)-2,2,2-trifluoroethanamine hydrochloride (1 :1) CAS:842169-83-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:(1R)-1-(4-Bromophenyl)-2,2,2-trifluoroethanamine hydrochloride (1 :1)
CAS.NO:842169-83-9
Synonyms:(1R)-1-(4-Bromophenyl)-2,2,2-trifluoroethanamine hydrochloride (1 :1)
Molecular Formula:C8H8BrClF3N
Molecular Weight:290.50800
HS Code:2921499090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:26.02000
Exact Mass:288.94800
LogP:4.51350
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like (1R)-1-(4-Bromophenyl)-2,2,2-trifluoroethanamine hydrochloride (1 :1) chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(1R)-1-(4-Bromophenyl)-2,2,2-trifluoroethanamine hydrochloride (1 :1) physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(1R)-1-(4-Bromophenyl)-2,2,2-trifluoroethanamine hydrochloride (1 :1) Use and application,(1R)-1-(4-Bromophenyl)-2,2,2-trifluoroethanamine hydrochloride (1 :1) technical grade,usp/ep/jp grade.
Related News: The U.K. government previously purchased more than 380 million rapid tests from Innova, to help set up programs capable of screening millions of people per day—in the run-up to offering free COVID-19 testing nationwide at least twice per week. (1R)-1-(4-Bromophenyl)-2,2,2-trifluoroethanamine hydrochloride (1 :1) manufacturer Same as Imbruvica’s original monotherapy use, the Venclexta combo offers a convenient oral treatment, while the drug’s two other approved cocktails—with Gazyva or Roche’s Rituxan—involve infusions. (1R)-1-(4-Bromophenyl)-2,2,2-trifluoroethanamine hydrochloride (1 :1) supplier For Jefferies, this “has not been demonstrated to convincingly reduce Abeta plaque burden, in our view.” The firm forecasts $3 billion in global sales for gantenerumab, but at a striking 0%, “so probability so no contribution.” (1R)-1-(4-Bromophenyl)-2,2,2-trifluoroethanamine hydrochloride (1 :1) vendor For Jefferies, this “has not been demonstrated to convincingly reduce Abeta plaque burden, in our view.” The firm forecasts $3 billion in global sales for gantenerumab, but at a striking 0%, “so probability so no contribution.” (1R)-1-(4-Bromophenyl)-2,2,2-trifluoroethanamine hydrochloride (1 :1) factory Same as Imbruvica’s original monotherapy use, the Venclexta combo offers a convenient oral treatment, while the drug’s two other approved cocktails—with Gazyva or Roche’s Rituxan—involve infusions.
